Pharmaceutical Industry Investments Boosting CIPN Market Development The Asia-Pacific region is expected to witness the fastest growth in the chemotherapy-induced peripheral neuropathy market. Rising healthcare investments, improving cancer treatment infrastructure, and increasing awareness about neuropathy management are contributing to regional market expansion.
The chemotherapy-induced peripheral neuropathy (CIPN) treatment market is gaining significant...
0 Compartilhamentos
23 Visualizações